Myomo offers revolutionary MyoPro braces that enhance mobility for upper limb disabilities due to various neurological conditions. The company is experiencing a record number of orders, leading to ...
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Myomo, Inc., a wearable medical robotics company, has achieved recent momentum fitting and delivering MyoPro to adolescent users. Approved to assist young adults ...
Myomo, Inc. MYO recently achieved a significant milestone with its MyoPro device. The company's request to the Centers for Medicare and Medicaid Services (CMS) to reclassify the MyoPro as a brace has ...
Good day and welcome to Myomo's Second Quarter of 2024 Earnings Call. All participants are in listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask ...
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb ...
Alliance Global Partners raised the firm’s price target on Myomo (MYO) to $6.75 from $6 and keeps a Buy rating on the shares after the company reported Q4 results that were ahead of the firm’s ...
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb ...
Standard Medicare Part B Patients now have access to the MyoPro, which will be reimbursed on a lump sum basis The MyoPro has already been covered and paid on a rental basis for five Medicare ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback